全文获取类型
收费全文 | 7830篇 |
免费 | 437篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 198篇 |
妇产科学 | 298篇 |
基础医学 | 1517篇 |
口腔科学 | 111篇 |
临床医学 | 659篇 |
内科学 | 1280篇 |
皮肤病学 | 208篇 |
神经病学 | 1002篇 |
特种医学 | 415篇 |
外国民族医学 | 1篇 |
外科学 | 873篇 |
综合类 | 50篇 |
预防医学 | 333篇 |
眼科学 | 125篇 |
药学 | 571篇 |
中国医学 | 11篇 |
肿瘤学 | 560篇 |
出版年
2021年 | 66篇 |
2020年 | 58篇 |
2019年 | 107篇 |
2018年 | 119篇 |
2017年 | 93篇 |
2016年 | 162篇 |
2015年 | 180篇 |
2014年 | 201篇 |
2013年 | 260篇 |
2012年 | 400篇 |
2011年 | 422篇 |
2010年 | 283篇 |
2009年 | 244篇 |
2008年 | 399篇 |
2007年 | 416篇 |
2006年 | 419篇 |
2005年 | 392篇 |
2004年 | 365篇 |
2003年 | 397篇 |
2002年 | 401篇 |
2001年 | 110篇 |
2000年 | 128篇 |
1999年 | 148篇 |
1998年 | 127篇 |
1997年 | 96篇 |
1996年 | 71篇 |
1995年 | 70篇 |
1994年 | 62篇 |
1993年 | 71篇 |
1992年 | 89篇 |
1991年 | 79篇 |
1990年 | 86篇 |
1989年 | 75篇 |
1988年 | 75篇 |
1987年 | 67篇 |
1986年 | 44篇 |
1985年 | 73篇 |
1984年 | 48篇 |
1983年 | 56篇 |
1982年 | 48篇 |
1981年 | 41篇 |
1980年 | 38篇 |
1979年 | 55篇 |
1978年 | 41篇 |
1977年 | 40篇 |
1976年 | 46篇 |
1974年 | 33篇 |
1955年 | 45篇 |
1954年 | 38篇 |
1932年 | 41篇 |
排序方式: 共有8288条查询结果,搜索用时 15 毫秒
51.
52.
53.
46 patients suffering from various malignancies (17 non Hodgkin lymphomas, 12 Hodgkin's diseases, 11 acute leukaemias, 4 myelomas, 2 carcinomas), 6 patients with haematological disorders such as ITP, SAA, myeloproliferative disease, LAS and 3 patients without preexisting disease were treated with acyclovir for herpes virus infection diagnosed by clinical means. All but 7 patients had been given intensive treatment with various cytostatic agents and/or irradiation. Most patients were treated with 1500 mg acyclovir daily for 5 to 13 days. Dosage was adjusted according to renal function and clinical response in the remaining 10 cases. 11 patients received intravenous immunoglobulins in addition. Side effects were negligible (local irritation, minimal rise in serum creatinine levels in 5 patients). All patients responded to treatment; 6 patients complained of severe neuralgia lasting for more than one month; 5 patients relapsed. 相似文献
54.
Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin's disease 总被引:2,自引:0,他引:2
Ernst-Dietrich Kreuser Heinz Völler Christian Behles Klaus Schröder Alexander Uhrig Angela Besserer Eckhard Thiel 《British journal of haematology》1993,84(4):615-622
Summary. The impact of valvular, myocardial and pericardial abnormalities on cardiac haemodynamics in patients treated for Hodgkin's disease with COPP/ABVD with and without mediastinal irradiation was determined in 49 patients 2–10 years after induction therapy. Diagnostic procedures to evaluate cardiac function consisted of history, physical examination, exercise bicycle stress test, M-mode two-dimensional and pulsed Doppler echocardiography. No patient reported symptoms related to cardiomyopathy, and only one of the 49 had evidence of coronary heart disease. Pericardial thickening was seen on echocardiograms in 19/49 patients (38.8%), valvular thickening in 21/49 (42·9%), and reduced fractional shortening in 9/49 (18·4%). The Doppler-derived mean E and A (±SD) of transmitral flow were 0·75 ± 0·14 m/s and 0·56 ± 0·09 m/s, respectively, in patients receiving chemotherapy and 0·81 ± 0.19 m/s and 0·63 ± 0·20 m/s in those with additional mediastinal irradiation. There was no statistically significant difference between mean E and A in transmitral flow in patients treated for Hodgkin's disease and control subjects. Furthermore, the transtricuspid and hepatic vein flow velocities did not differ significantly. Although the present study demonstrates high frequencies of pericardial and valvular thickening in patients treated for Hodgkin's disease with the COPP/ABVD regimen with or without mediastinal irradiation, it showed no impact on cardiac flow velocities. The abnormalities might thus be of minor clinical relevance in these patients. 相似文献
55.
56.
To provide baseline information for the "local" therapy of the glioblastoma multiforme (GBM), whole-brain histological sections of 15 untreated GBM's were studied to determine the distribution of neoplastic cells. These findings were then compared with the computerized tomography (CT) scans in 11 cases in order to determine the extent to which the peripheral portion of the neoplasm can be estimated by the presence of a low-density area without contrast enhancement. The results of the histological study confirmed the marked heterogeneity of GBM's and disclosed a great variability in the geometry, extent, and character of the peripheral "infiltrating" margin. In spite of the widely held concept that glioblastomas are localized within 2 cm of the contrast-enhanced rim, there were three cases in this two-dimensional study in which this distance was exceeded, and it seems likely that three-dimensional reconstructions would have detected additional cases in which neoplastic cells extended beyond this arbitrary limit. Only three of the 15 GBM's were restricted to the distribution of one internal carotid or one vertebral artery. To the extent that the neoplasms in the present series are representative, this suggests that glioblastomas will be difficult to treat successfully by intra-arterial therapy using existing therapeutic agents. Correlations of histological sections with the CT scans revealed that the vast majority of the neoplastic tissue was contained within the contrast-enhancing and "peritumoral" areas of low density, but that in five cases fingers of neoplasm extended for short distances beyond the outer margin of the latter region. This indicates that the distribution of cells of a GBM cannot be inferred from CT images since the "peritumoral" area of low density can over- or underestimate the extent of the lesion. 相似文献
57.
Michael Fromm Wolfgang E. Berdel Hans D. Schick Susanne Danhauser-Riedl Ulrich Fink Wolfgang Remy Anneliese Reichert Anke Ankele Heinz W. Präuer Jörg R. Siewert Johann Rastetter 《Investigational new drugs》1988,6(3):189-194
Summary Carbetimer, a new synthetic low molecular weight polyelectrolyte with a novel structure displayed antitumor activiy in a number of animal tumor model systems and in vitro investigations. Based on these findings it was brought to a phase I clinical trial in patients with advanced malignant disease after failure of conventional treatment or with no conventional treatment available. Forty-eight patients received 98 courses. The schedule was a one hour i.v. infusion every four weeks. The starting dose was 180 mg/m2 and dose escalation was performed according to a modified Fibonacci formula up to 16,690 mg/m2. At least three patients were treated at each dose level and each patient was eligible to receive repeat courses at the same dose, until progressive disease or dose-limiting toxicity intervened. No hematological toxicity was encountered. Some adverse effects such as reversible proteinuria, hypercalcaemia, pain at infusion site, nausea and vomiting and fatigue were seen partly in a dose-related manner but did not represent the maximum tolerated dose (MTD). The limiting toxicity at the highest dose level of 16,690 mg/m2 consisted of ocular symptoms (light flashes) accompanied by a modest decrease of blood pressure and nausea or vomiting during a one hour infusion. 16,690 mg/m2/1 hour was considered the MTD. There were four deaths on study, all considered diseaserelated. Fourteen patients had stable disease for more than two courses, which, however, could also be explained by the natural course of disease. No clear-cut antitumor responses were noted in our study center.The recommended dose for phase II trials derived from our results is 12,550 mg/m2/2 hours. However, with regard to experiences in other phase I studies, the subsequent phase II studies will be performed with a dose of 6,500 mg/m2. 相似文献
58.
Heinz Schurawitzki M.D. Paul C. Hajek Josef Kramer Florian Grabenwöger Walter Klepetko Anton Moritz 《Cardiovascular and interventional radiology》1989,12(1):10-13
In a radiologic search for embolized leaflets of Edwards-Duromedics bileaflet valves in 2 patients, the embolized fragments were localized in the iliac vessels using computed tomography. Sonography was successful in one case and standard X-ray films of the abdomen were negative in both cases.In vitro investigations with Björk-Shiley and Edwards-Duromedics leaflets suggested that standard X-ray films of the abdomen and pelvis should be considered as the first investigational technique. If negative, computed tomography of the lower abdomen should be done. 相似文献
59.
CGP 6809 — A new nitrosoureido-sugar derivative with activity in human tumor xenografts 总被引:1,自引:0,他引:1
Heinz H. Fiebig Karl H. Widmer Bernd R. Winterhalter Georg W. Löhr 《Cancer chemotherapy and pharmacology》1989,23(6):337-340
Summary CGP 6809 [ethyl-6-deoxy-3,5-di-O-methyl-6-(3-methyl-3-nitrosoureido)--d-glucofuranoside] is a new methylnitrosoureido-sugar derivative that has been shown to be active against a broad spectrum of transplantable tumours in mice and rats [14]. We investigated the anti-tumour effect of CGP 6809 in ten selected, human tumour xenograft lines growing s. c. in nude mice. The p. o. administration of 125 mg/kg per day for 10–15 days was less toxic (lethality 12% in tumour-bearing nude mice) than the i. p. injection of 62.5 mg/kg per day (lethality 22%). The anti-tumour effect was similar for both application routes; two large bowel cancers responded to treatment with CGP 6809, rectal cancer CXF 158 showed a remission, and the rapidly growing, undifferentiated colonic cancer CXF 280 exhibited a transient no-change. Furthermore, remissions were observed in the epidermoid lung cancer LXF 322 and in thyroid cancer 117. Tumour progression was found in another epidermoid lung cancer and in three stomach cancers, one melanoma, and one soft tissure sarcoma. CGP 6809 is a promising new agent for clinical trials, especially for large bowel and epidermoid lung cancer.Supported in part by grant PTB 8467 from the Bundesminister für Forschung und Technologie, Bonn, FRG 相似文献
60.
Exchange diffusion of chloride in frog gastric mucosa 总被引:2,自引:0,他引:2
Durbin R. P.; Kitahara S.; Stahlmann K.; Heinz E. 《The American journal of physiology》1964,207(6):1177-1180